MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA)

Annals of the Rheumatic Diseases

Volumn 68, Issue 3, 2009, Pages 384-390

  Hetland, M L ^a   Ejbjerg, B ^a   Horslev Petersen K ^b   Jacobsen, S ^c   Vestergaard, A ^a   Jurik, A G ^d   Stengaard Pedersen, K ^d   Junker, P ^e   Lottenburger, T ^b   Hansen, I ^d   Andersen, L S ^b   Tarp, U ^d   Skjodt H ^a   Pedersen, J K ^b   Majgaard, O ^a   Svendsen, A J ^b   Ellingsen, T ^d   Lindegaard, H ^e   Christensen, A F ^e   Vallo J ^f   Torfing, T ^e   Narvestad, E ^a   Thomsen, H S ^a   Ostergaard M ^b   more..

^a Mental Health Services CPH   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e ODENSE UNIVERSITY HOSPITAL   (Denmark)

^f Aabenraa Hospital   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYCLOSPORIN; EPITOPE; HLA DR ANTIGEN; HLA DR1 ANTIGEN; HYDROXYCHLOROQUINE; METHOTREXATE; PLACEBO;

ADD ON THERAPY; ADULT; AGE DISTRIBUTION; ARTICLE; BONE EROSION; BONE SWELLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPENDENT VARIABLE; DISEASE ACTIVITY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; EXPLANATORY VARIABLE; FEMALE; HUMAN; JOINT SWELLING; MALE; METACARPOPHALANGEAL JOINT; MULTICENTER STUDY; MULTIPLE REGRESSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTOR VARIABLE; PRIORITY JOURNAL; RADIODIAGNOSIS; RANDOMIZED CONTROLLED TRIAL; REMISSION; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SMOKING; SYNOVITIS; WRIST;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BONE MARROW DISEASES; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; EDEMA; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE IMAGING; MALE; METACARPOPHALANGEAL JOINT; MIDDLE AGED; PROGNOSIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; WRIST JOINT;

EID: 61549139043     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2008.088245     Document Type: Article

References (38)

1. Hetland ML, Stengaard-Pedersen K, Junker P, Lottenburger T, Ellingsen T, Andersen LS, et al. Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study. Arthritis Rheum 2006;54:1401-9.
2. Korpela M, Laasonen L, Hannonen P, Kautlainen H, Leirisalo-Repo M, Hakala M, et al. Retardation of joint damage In patients with early rheumatoid arthritis by initial aggressive treatment with disease-modifying antirheumatic drugs: five-year experience from the FIN-RACo study. Arthritis Rheum 2004;50:2072-81.
3. Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004;364:263-9.
4. Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, et al. Comparison of treatment strategies In early rheumatoid arthritis: a randomized trial. Ann Intern Med 2007;146:406-15.
5. van der Kooij SM, de Vries-Bouwstra JK, Goekoop-Ruiterman YP, van Zeben D, Kerstens PJ, Gerards AH, et al. Limited efficacy of conventional DMARDs after initial methotrexate failure In patients with recent onset rheumatoid arthritis treated according to the disease activity score. Ann Rheum Dis 2007;66:1356-62.
6. van Zeben D, Hazes JM, Zwinderman AH, Vandenbroucke JP, Breedveld FC. Factors predicting outcome of rheumatoid arthritis: results of a followup study. J Rheumatol 1993;20:1288-96.
7. Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S, et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med 2007;146:797-808.
8. McQueen FM, Benton N, Perry D, Crabbe J, Robinson E, Yeoman S, et al. Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later In patients with rheumatoid arthritis. Arthritis Rheum 2003;48:1814-27.
9. Lindegaard HM, Vallo J, Horslev-Petersen K, Junker P, Ostergaard M. Low-cost, low-field dedicated extremity magnetic resonance imaging in early rheumatoid arthritis: a 1-year follow-up study. Ann Rheum Dis 2006;65:1208-12.
10. Palosaari K, Vuotila J, Takalo R, Jartti A, Niemela RK, Karjalalnen A, et al. Bone oedema predicts erosive progression on wrist MRI In early RA - a 2-yr observational MRI and NC scintigraphy study. Rheumatology (Oxford) 2006;45:1542-8.
11. Haavardsholm EA, Boyesen P, Ostergaard M, Schildvold A, Kvien TK. Magnetic resonance imaging findings In 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression. Ann Rheum Dis 2008;67:794-800.
12. Symmons DP. Environmental factors and the outcome of rheumatoid arthritis. Best Pract Res Clin Rheumatol 2003;17:717-27.
13. Hetland ML, Stengaard-Pedersen K, Junker P, Lottenburger T, Hansen I, Andersen LS, et al. Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study. Ann Rheum Dis 2008;67:815-22.
14. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, etal. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
15. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
16. Thorsen H, Hansen TM, McKenna SP, Sorensen SF, Whalley D. Adaptation into Danish of the Stanford Health Assessment Questionnaire (HAQ) and the Rheumatoid Arthritis Quality of Life Scale (RAQoL). Scand J Rheumatol 2001;30:103-9.
17. Vasiliauskiene L, Wilk A, Hoier-Madsen M. Prevalence and clinical significance of antikeratin antibodies and other serological markers In Lithuanian patients with rheumatoid arthritis. Ann Rheum Dis 2001;60:459-66.
18. Kimura A, Sasazuki T. Eleventh International Histocompatibility workshop reference protocol for the HLA DNA typing technique. In: Tsuji K, Aizawa M, Sasazuki M, eds. HLA 1991. Oxford: Oxford University Press, 1992.
19. Ostergaard M, Peterfy C, Conaghan P, McQueen F, Bird P, Ejbjerg B, et al. OMERACT rheumatoid arthritis magnetic resonance imaging studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system. J Rheumatol 2003;30:1385-6.
20. Nørgaard F. Earliest roentgenological changes In polyarthritis of the rheumatoid type: rheumatoid arthritis. Radiology 1965;85:325-9.
21. van der Heijde DM. How to read radiographs according to the Sharp/van der Heljde method. J Rheumatol 1999;26:743-5.
22. R Development Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2006. Available at http://www.R-project.org (accessed 21 November 2008).
23. McQueen FM, Stewart N, Crabbe J, Robinson E, Yeoman S, Tan PL, et al. Magnetic resonance imaging of the wrist In early rheumatoid arthritis reveals progression of erosions despite clinical improvement. Ann Rheum Dis 1999;58:156-63.
24. Savnik A, Malmskov H, Thomsen HS, Graff LB, Nielsen H, Danneskiold-Samsoe B, et al. MRI of the wrist and finger joints In inflammatory joint diseases at 1-year interval: MRI features to predict bone erosions. Eur Radiol 2002;12:1203-10.
25. Tanaka N, Sakahashi H, Ishil S, Sato E, Hirose K, Ishima T. Synovial membrane enhancement and bone erosion by magnetic resonance imaging for prediction of radiologic progression In patients with early rheumatoid arthritis. Rheumatol Int 2005;25:103-7.
26. Forslind K, Ahlmen M, Eberhardt K, Hafstrom I, Svensson B. Prediction of radiological outcome in early rheumatoid arthritis In clinical practice: role of antibodies to citrulllnated peptides (antl-CCP). Ann Rheum Dis 2004;63:1090-5.
27. Lindqvist E, Eberhardt K, Bendtzen K, Heinegard D, Saxne T. Prognostic laboratory markers of joint damage in rheumatoid arthritis. Ann Rheum Dis 2005;64:196-201.
28. Syversen SW, Gaarder Pl, Goll GL, Odegard S, Haavardsholm EA, Mowinckel P, et al. High anti-cyclic citrulllnated peptide levels and an algorithm of four variables predict radiographic progression In patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann Rheum Dis 2008;67:212-7.
29. Berglin E, Johansson T, Sundin U, Jidell E, Wadell G, Hallmans G, et al. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic cltrullinated peptide before and at disease onset, and by IgA-RF at disease onset. Ann Rheum Dis 2006;65:453-8.
30. Mattey DL, Thomson W, Ollier WE, Batley M, Davies PG, Gough AK, et al. Association of DRB1 shared epitope genotypes with early mortality in rheumatoid arthritis: results of eighteen years of followup from the early rheumatoid arthritis study. Arthritis Rheum 2007;56:1408-16.
31. Young-Min S, Cawston T, Marshall N, Coady D, Christgau S, Saxne T, et al. Blomarkers predict radiographic progression in early rheumatoid arthritis and perform well compared with traditional markers. Arthritis Rheum 2007;56:3236-47.
32. Pedersen M, Jacobsen S, Garred P, Madsen HO, Klarlund M, Svejgaard A, et al. Strong combined gene-environment effects in anti-cyclic citrulllnated peptide-positive rheumatoid arthritis: a nationwide case-control study in Denmark. Arthritis Rheum 2007;56:1446-53.
33. Finckh A, Dehler S, Costenbader KH, Gabay C. Cigarette smoking and radiographic progression In rheumatoid arthritis. Ann Rheum Dis 2007;66:1066-71.
34. Manfredsdottir VF, Vikingsdottir T, Jonsson T, Geirsson AJ, Kjartansson 0, Heimisdottlr M, et al. The effects of tobacco smoking and rheumatoid factor seropositlvity on disease activity and joint damage in early rheumatoid arthritis. Rheumatology (Oxford) 2006;45:734-40.
35. McQueen FM, Ostendorf B. What is MRI bone oedema In rheumatoid arthritis and why does it matter? Arthritis Res Ther 2006;8:222.
36. Jimenez-Boj E, Nobauer-Huhmann I, Hanslik-Schnabel B, Dorotka R, Wanivenhaus AH, Kainberger F, et al. Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation In rheumatoid arthritis. Arthritis Rheum 2007;56:1118-24.
37. Ejbjerg BJ, Narvestad E, Jacobsen S, Thomsen HS, Ostergaard M. Optimised, low cost, low field dedicated extremity MRI is highly specific and sensitive for synovitis and bone erosions in rheumatoid arthritis wrist and finger joints: comparison with conventional high field MRI and radiography. Ann Rheum Dis 2005;64:1280-7.
38. Haavardsholm EA, Ostergaard M, Ejbjerg BJ, Kvan NP, Uhlig TA, Lilleas FG, etal. Reliability and sensitivity to change of the OMERACT rheumatoid arthritis magnetic resonance imaging score in a multireader, longitudinal setting. Arthritis Rheum 2005;52:3860-7.